Ars Pharmaceuticals (SPRY)'s 30-day implied volatility (IV30) was 77.2% at the close on November 18, 2026, down from 86.7% the day before, against a 52-week range of 49.3% to 137.8%. Its 20-day historical volatility was 97.6%.
Data as of November 18, 2026.